Journal of Viral Hepatitis

Article	Citations
International disease burden of acute viral hepatitis among adolescents and young adults: An observational study	33
Issue Information	31
Issue Information	27
	26
Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine	24
Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England	23
Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination	23
Issue Information	22
Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study	22
Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab	22
240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C	20
The role of serum sphingolipids as potential biomarkers of non‐response to direct acting antiviral therapy in chronic hepatitis C virus infection	19
Clinical Observational Study on HBV Reactivation After Direct‐Acting Antiviral Therapy in HCV/HBV Coinfected Patients in Guizhou, China	18
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B	17
Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review	17
A cross‐sectional study of hepatitis C prevalence and correlates among persons who inject drugs in rural and non‐rural communities	16
Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐19	16
Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues	16
	15
Issue Information	15
Issue Information	15
Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study	14
Improvement of chronic HCV infection‐related depression, anxiety, and neurocognitive performance in persons achieving SVR‐12: A real‐world cohort study	14
Contribution of alcohol use in HIV/hepatitis C virus co‐infection to all‐cause and cause‐specific mortality: A collaboration of cohort studies	14
Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?	14

Trends and Socio‐Demographic Patterns of Hepatitis B Virus Hospitalisations in Poland: A 12‐Year Nationwide Analysis	14
Elevation of S2‐bound α1‐acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma	14
Reversibility of acute‐on‐chronic liver failure syndrome in hepatitis B virus‐infected patients with and without prior decompensation	14
Evaluation of Blood Droplet Volumes on the Cobas Plasma Separation Card for HCV RNA Testing in Resource‐Limited Settings	13
Integration and the risk of liver cancer—Is there a real risk?	13
Long‐Term Follow‐Up of Neuropsychiatric Symptoms After Sustained Virological Response to Interferon‐Free and Interferon‐Based Hepatitis C Virus Treatment	13
Sex‐related difference analyses of efficacy and safety in clinical trials of direct‐acting antivirals to treat chronic HCV genotype 1 and 3 infections	13
A Network Map of Intracellular Alpha‐Fetoprotein Signalling in Hepatocellular Carcinoma	13
Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment	12
A declaration from people living with hepatitis B: A call for a whole person approach	12
TRPM2 regulates autophagy to participate in hepatitis B virus replication	12
The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis	11
An updated assessment of hepatitis delta prevalence among adults in Canada: A meta‐analysis	11
Issue Information	11
Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good Option! The DEVICHO Study	10
Epidemiology and Outcomes of Hepatitis E Virus‐Associated Hospitalisations in the United States With a Focus on Pregnancy: A Nationwide Population Study, 1998–2020	10
Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study	10
Adenovirus vector encoding TPPII ignites HBV‐specific CTL response by activating autophagy in CD8+ T cell	10
Epidemiological Burden of Hepatitis Delta Virus in the United States	10
Issue Information	10
Prevalence of hepatitis C in sexual assault survivors presenting to a SANE clinic: A descriptive analysis	10
Strategies to increase primary care provider capacity for hepatitis C care: The California ECHO‐PLUS study	10
Hepatitis E prevalence and infection in solid‐organ transplant recipients in the United States	10
Serum HBV RNA is associated with liver fibrosis regression in HBeAg‐positive chronic hepatitis B patients treated with nucleos(t)ide analogues	10
Safe co‐administration of direct‐acting antivirals and direct oral anticoagulants among patients with hepatitis C virus infection: An international multicenter retrospective cohort study	10
Systematic Screening for Hepatitis B, C, and HIV and Linkage to Care in Patients With Mental Health Disorders Admitted to the Emergency Department	10
The changing epidemiology of delta hepatitis in Türkiye over three decades: A systematic review	10
Clinical and histological features of patients with chronic hepatitis B virus infection in the grey zone	9
Sustainable and equivalent improvements in symptoms and functional well‐being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection:	9
	9
Electronic nose versus quadrupole mass spectrometry for identifying viral hepatitis C patients	9
Measuring stigma associated with hepatitis B virus infection in Sierra Leone: Validation of an abridged Berger HIV stigma scale	9
Network‐basedstrategies to combatHCV: Examining social and spatial drivers of transmission amongPWIDin New Delhi	9
Challenges of hepatitis B treatment in rural Sub‐Saharan Africa: Treatment initiation and outcomes from a public hospital‐based clinic in Kono, Sierra Leone	8
HCV hotline facilitates Hepatitis C elimination during the COVID‐19 pandemic	8
Does hepatitis delta virus have a preference for hepatitis B virus genotype? A systematic review of the literature	8
The altered HLA‐DQ expression in peripheral blood T cells of chronic hepatitis B patients characterizes the function of T cells	8
	8
Viral hepatitis in pregnancy	8
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver‐related complications in patients with chronic hepatitis C receiving direct‐acting antiviral agents	8
Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis	8
Hepatitis D virus infection: Progress on the path toward disease control and cure	8
Baseline and on‐treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals	8
Risk of drug‐induced liver injury in chronic hepatitis B and tuberculosis co‐infection: A systematic review and meta‐analysis	8
Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta‐analysis	8
	8
Cover image	8
Laboratory monitoring and antiviral treatment for chronic hepatitis B among routine care patients in the United States	7
The Efficacy and Sustainability of an Implementation Intervention (FOCUS Program) on Linkage to Hepatitis C Care Time at a Community Health Center in the Deep South: A Longitudinal Study Ba	7
Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi‐ethnic population: Universal screening is more comprehensive	7

Prognostic value of genotyping in hepatocellular carcinoma: A systematic review	7
Performance of HCV core antigen and PCR testing in a predominantly genotype 3 population	7
CHB patients with rtA181T‐mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes	7
Frequency, Severity and Impact of Pegylated Interferon Alpha–Associated Flares in Hepatitis D Infection	7
The immune landscape in hepatitis delta virus infection—Still an open field	7
Duration of Nucleos(t)ide Analogue Treatments in Patients With Chronic Hepatitis B Virus Infection in the United States	7
Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™	7
	7
Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather)	7
VirA+EmiC project: Evaluating real‐world effectiveness and sustainability of integrated routine opportunistic hepatitis B and C testing in a large urban emergency department	7
A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP‐HEPC t	7
Dynamic personalized prediction of the individual liver‐related risk after sustained viral response in HCV patients	7
Hepatitis B e antigen and e antibody in a multi‐ethnic cohort of adult chronic hepatitis B virus patients followed at a single liver unit for a period of 20 years	7
Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis	6
Knowledge and Perceptions of Hepatitis B in Immigrant Populations: A Systematic Review and Thematic Synthesis of Qualitative Research	6
Hepatitis Delta Coinfection Rates and All‐Cause Mortality Among Hepatitis B‐Infected Veterans in the USA	6
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon‐alfa	6
Phase 1 study of safety and tolerability of an oral contraceptive containing low‐dose ethinyl oestradiol combined with glecaprevir/pibrentasvir treatment in healthy premenopausal women	6
Impact of COVID‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs	6
Performance Evaluation of the Elecsys HCV Duo Immunoassay in the Public Healthcare Setting in Cape Town, South Africa	6
Balancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial	6
Risk factors for hepatitis C virus infection at a large urban emergency department	6
Role of hepatitis B surface antibody in seroreversion of hepatitis B surface antigen in patients achieving hepatitis B surface antigen loss with pegylated interferon‐based therapy	6
Screening rates for hepatitis B and C among low‐income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study	6
Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct‐acting antivirals	6
Issue Information	6
CORRIGENDUM	6
A novel test and treat program for hepatitis C virus infection utilizing HCV core antigen testing, among police and general population, Islamabad, Pakistan, 2022	6
MELD score < 18 rule out 28‐day ACLF development among inpatients with hepatitis B‐related previous compensated liver disease	6
Preferences and feasibility of long‐acting technologies for treatment of hepatitis C virus in low‐ and middle‐income countries: A survey of providers and policymakers	6
A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons	6
	6
Barriers and enablers to people‐centred viral hepatitis care in Vietnam and the Philippines: Results of a patient journey mapping study	6
	6
	6
Mortality and morbidity related to hepatitis C virus infection in hospitalized adults—A propensity score matched analysis	6
Genetic substructure and host‐specific natural selection trend across vaccine‐candidate ORF‐2 capsid protein of hepatitis‐E virus	5
Cover Image	5
Hepatocytes and Hepatic Stellate Cells Carry Different Levels of DNA Damage due to Their Sensitivity to Oxidative Stress in Chronic Hepatitis B	5
Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure	5
Post‐vaccination serologic testing of infants born to hepatitis B surface antigen‐positive mothers is more cost‐effective in Zhejiang Province, China: A Markov chain analysis	5
Reply to ‘Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial’	5
	5
Persistence of antibodies 5 years after hepatitis B vaccination in preterm birth children: A retrospective cohort study using real‐world data	5
Outcomes of a 1‐Year Pilot Study Implementing Universal Hepatitis Delta Virus Testing Among Veterans With Chronic Hepatitis B	5
A Programme of Hepatitis C Surveillance With Active Linkage to Care (HEAL) for Inpatients in Two Tertiary Hospitals in Jiangsu, China	5
Cigarette Smoking Is Associated With Lower Chance of Hepatitis B Surface Antigen Seroclearance and Altered Host Immunity	5
Issue Information	5
Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real‐world analysis	5
Issue Information	5
MiRNome Profiling of Circulating Extracellular Vesicles in Patients With Chronic Hepatitis D Undergoing Pegylated Interferon Alpha Treatment	5
Prevalence of hepatitis B virus (HBV) and latent tuberculosis co‐infection and risk of drug‐induced liver injury across two large HBV cohorts in the United	5
Sequence characterization of extracellular HBV RNA in patient plasma	5
	5
Outcomes of Assisted Reproductive Technology in Women With Hepatitis B Infection	5
Severe acute hepatitis of unknown origin in children: Is it still a mystery? What role does adenovirus play?	5
Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus‐Related Cirrhosis	5
The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection	5
Substance use and CD4/CD8 ratio in HIV/HCV co‐infected people receiving direct‐acting antiviral treatment (ANRS CO13 HEPAVIH)	5
Depletion of circ_0088046 suppressed cell growth and motility of hepatocellular carcinoma via circ_0088046‐miR‐1299‐RTKN2 ceRNA pathway	5
A morphometric analysis of hepatitis B subviral particles shows no correlation of filament proportion and length with clinical stage and genotype	5
Issue Information	4
Protective Role of Coffee in Chronic Liver Disease: A Focus on Processing	4
Hepatitis after gene therapy, what are the possible causes?	4
Substance use and CD4/CD8 ratio in HIV/HCV co‐infected people receiving direct‐acting antiviral treatment (ANRS CO13 HEPAVIH): Authors' reply	4
Impact of treatment with direct‐acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co‐infected individuals	4
Issue Information	4
Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection With Interferon or Direct Antiviral Therapy	4
Closing the hepatitis C treatment gap: United States strategies to improve retention in care	4
Screening, Prevalence and Management of Chronic Viral Hepatitis C in Mental Health Setting: Towards the Eradication of A Forgotten Reservoir	4
Impact of Universal Screening for HDV in HBV‐Infected Patients on Chronic HDV Detection Rate in Israel	4
Towards hepatitis C elimination in France: Scanvir, an effective model to test and treat drug users on dedicated days	4
Efficacy and safety of pan‐genotypic sofosbuvir and velpatasvir in patients with hepatitis C and HIV coinfection on dolutegravir‐based antiretroviral therapy	4
Reply to: ‘Abnormal liver function tests and coronavirus disease 2019: A close relationship’	4
	4
	4
Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment	4
Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States	4
Issue Information	4
Lower Serum Albumin Level: A Prospective Risk Predictor of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection	4

Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy	4
Prevalence and Factors Associated With Hepatitis B Virus Infection in Tigray Region, Northern Ethiopia	4
Factors influencing compliance with Hepatitis C treatment in patients transitioning from prison to community—A summary scoping review	4
	4
Demographic and Clinical Characteristics of Patients With Hepatitis C and Hepatitis B Co‐Infection, Georgia, 2017–2023	4
Determining the frequency and characteristics of Hepatitis C reinfections in North East England	4
	4
Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial	4
Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B‐coinfected adults in care in the United States	4
Testing to sustain hepatitis C elimination targets in people who inject drugs: A network‐based model	4
Shear wave elastography: How well does it perform in chronic hepatitis D virus infection?	4
Prevalence of hepatitis C among pregnant women in an Appalachian population	4
Chronic viral hepatitis C micro‐elimination program using telemedicine in Guigang city	4
Hepatitis C prevalence and elimination planning in Pakistan, a bottom‐up approach accounting for provincial variation	4
HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre‐ and posttreatment: a multicentre observational cohort study	4
Trends in Use of Direct‐Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016–2024	4
Test characteristics for combining non‐invasive liver fibrosis staging modalities in individuals with Hepatitis C virus	4